BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11363901)

  • 1. Remune trials recruiting.
    PI Perspect; 1996 Sep; (No 19):17. PubMed ID: 11363901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.
    Chantratita W; Sukeepaisarncharoen W; Chandeying V; Kulpradist S; Israngkura Na Ayudhtaya B; Rugpao S; Sirawaraporn W; Boonshuyar C; Churdboonchart V
    HIV Med; 2004 Sep; 5(5):317-25. PubMed ID: 15369506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New biological monitoring of HIV infection].
    Morand-Joubert L
    Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs.
    Turner JL; Kostman JR; Aquino A; Wright D; Szabo S; Bidwell R; Goodgame J; Daigle A; Kelley E; Jensen F; Duffy C; Carlo D; Moss RB
    HIV Med; 2001 Apr; 2(2):68-77. PubMed ID: 11737381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy.
    Sukeepaisarncharoen W; Churdboonchart V; Kulpradist S; Isarangkura Na Ayudthya B; Rugpao S; Chandeying V; Sirawaraporn W; Carlo D; Moss RB
    HIV Clin Trials; 2001; 2(5):391-8. PubMed ID: 11673813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for HIV--Remune returns.
    TreatmentUpdate; 2004 Oct; 16(6):3. PubMed ID: 17219678
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines. Study finds Remune reduces risk of virologic failure.
    TreatmentUpdate; 2004 Oct; 16(6):3-4. PubMed ID: 17225281
    [No Abstract]   [Full Text] [Related]  

  • 8. Honing the immune attack on HIV.
    Gilden D
    GMHC Treat Issues; 1996 Dec; 10(12):8-11. PubMed ID: 11364019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA advisory committees meet January 26 on Salk HIV-1 immunogen.
    AIDS Treat News; 1995 Jan; (No 214):1-2. PubMed ID: 11362184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebuilding immunity with Remune.
    Whitfield L
    Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 immunogen.
    Lein B
    PI Perspect; 1995 May; (no 16):17. PubMed ID: 11362424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 immunogen (remune).
    Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remune trial will stop; new trials planned.
    James JS
    AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boost for the immune system.
    TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up.
    Levine AM; Groshen S; Allen J; Munson KM; Carlo DJ; Daigle AE; Ferre F; Jensen FC; Richieri SP; Trauger RJ; Parker JW; Salk PL; Salk J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):351-64. PubMed ID: 8601221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.
    Kovacs JA; Vogel S; Albert JM; Falloon J; Davey RT; Walker RE; Polis MA; Spooner K; Metcalf JA; Baseler M; Fyfe G; Lane HC
    N Engl J Med; 1996 Oct; 335(18):1350-6. PubMed ID: 8857018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
    DeMaria A; Kunches L; Mayer K; Cohen C; Epstein P; Werner B; Day J; DeCristofaro J; Landers S; Tang Y; Coady W
    J Hum Virol; 2000; 3(4):182-92. PubMed ID: 10990166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral phenotype and genotype as markers in clinical trials.
    Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S25-34. PubMed ID: 7552510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remune. Immune Response.
    Lai D; Jones T
    Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression.
    James JS
    AIDS Treat News; 1998 Jul; (No 298):1-5. PubMed ID: 11365597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.